Name | 5-(4-fluorophenyl)-2-methyl-1,3-thiazole-4-carboxylic acid |
---|---|
Synonyms |
4-Thiazolecarboxylic acid, 5-(4-fluorophenyl)-2-methyl-
5-(4-Fluorophenyl)-2-methyl-1,3-thiazole-4-carboxylic acid |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 376.5±27.0 °C at 760 mmHg |
Molecular Formula | C11H8FNO2S |
Molecular Weight | 237.250 |
Flash Point | 181.5±23.7 °C |
Exact Mass | 237.025970 |
PSA | 78.43000 |
LogP | 1.81 |
Vapour Pressure | 0.0±0.9 mmHg at 25°C |
Index of Refraction | 1.610 |
HS Code | 2934100090 |
---|
~93% 433283-22-8 |
Literature: Actelion Pharmaceuticals Ltd. Patent: US2010/222600 A1, 2010 ; Location in patent: Page/Page column 23 ; US 20100222600 A1 |
Precursor 1 | |
---|---|
DownStream 0 |
HS Code | 2934100090 |
---|---|
Summary | 2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |